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ABSTRACT 
 
Mouse embryonic stem cells can be differentiated into multiple cell types and can 
serve as an excellent model for studying developmental processes in vitro. In particular, 
stem cells can be differentiated into forebrain-like neurons, allowing investigation of 
nervous system development at single cell resolution.  Eph receptor tyrosine kinases and 
their ephrin ligands play a critical role during in vivo cortical development, particularly 
during axon guidance. Preliminary data has shown that EphRs and ephrins are expressed 
during in vitro differentiation. In addition, we see EphA7 localization at the face of neural 
rosettes, where it co-expresses with markers of neuroblast identity. However, the role of 
Eph receptors and ephrins in neurogenesis is not well understood.  
Previous literature had shown that ephrin-A5 and EphA7 can function to balance 
cortical apoptosis during embryogenesis. We hypothesized that EphR/ephrin signaling 
may be required to balance apoptosis during in vitro neural development. A monolayer 
differentiation protocol was used to generate cells of forebrain fate at high yield. RNAi 
knockdown of EphA3, EphA4, and EphA7, was used to identify which Eph receptor was 
contributing to the apoptotic effect individually. It was found that transient knockdown of 
EphA3 and EphA4 fail to cause changes in apoptosis levels. However, knockdown of 
EphA7 at differentiation days 4 through 8 lead to a reduction in apoptosis suggesting that 
EphA7 can positively regulate cell death during differentiation.  These data confirm that 
in vivo developmental events such as apoptosis can be modeled in an in vitro system. The 
innovative methods developed throughout the process of this research project may 
eventually prove to be useful in the analysis of other neurodevelopmental processes.  
 v
Key Words: embryonic stem cell, in vitro differentiation, neurogenesis, ephrin, Eph 
receptor, apoptosis, siRNA, cell sorter, transfection, flow cytometry.  
 
Abbreviations:  
mESC: mouse embryonic stem cell 
ICM: inner cell mass 
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CHAPTER 1: INTRODUCTION  
 
Mouse Embryonic Stem Cells 
Embryonic stem (ES) cells are “pluripotent” cells meaning that in theory they are 
able to differentiate into any tissue or cell type, as opposed to “multipotent” cells which 
have lineage restriction to differentiate to cell types within the same progenitor type(1) . 
In 1908, the Russian scientist Alexander Maksimov assigned the term “stem cell” to 
describe cells that had “self-renewal” properties, progressing through numerous cycles of 
cell division while preserving their original or undifferentiated state(2) . In 1981 the first 
mouse embryonic stem cells (mESCs) were extracted from the inner cell mass (ICM) of a 
mouse embryo(3, 4) . In 1998, the embryonic stem cell line was revealed as a 
revolutionary scientific platform for their ability to accurately illustrate developmental 
processes in vitro(5) . Thompson and his team used donated human embryos, originally 
intended for in vitro fertilization, to conclude that the high telomerase activity exhibited 
in stem cells contributes to their infinite replicative life span(5) . 
Today, targeted ES cell differentiation for the generation of new neurons holds 
excellent promise for those diagnosed with degenerative brain disorders such as 
Alzheimer’s or Parkinson’s disease(6, 7) . In addition, because stem cells can be grown 
indefinitely in culture, they can serve as a cost effective model for studying 
developmental processes. Finally, new possibilities have arisen from the potential ability 
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to repair damaged neural tissue by using embryonic stem cells to generate neural stem 
cells(8) .  
The differentiation of stem cells into neurons has been optimized using a 
monolayer differentiation protocol developed by Austin Smith(9) . Typically, when stem 
cells are allowed to freely differentiate into other cell types in culture, the outcome can 
yield variable and heterogeneous outcomes. However, this in vitro differentiation 
protocol generates cells in high yield that are broadly of forebrain fate. This method not 
only allows the study of neurogenesis in vitro at single cell resolution but also provides a 
platform to examine intrinsic and extrinsic mechanisms involved in neural specification 
provided by signaling(10-12) . 
Neurogenesis and the Role of Ephrins 
  The initial stage of vertebrate neurogenesis includes the induction and patterning 
of a neuron forming or neurogenic region along the primitive streak, followed by the 
birth and migration of neurons and glial cells (Figure 1) (13) . Next, axonal growth cones 
migrate towards their designated targets and subsequently form synaptic connections(14) 
. Many regions of the brain, including the cortex, develop in a layer-specific manner(15-
18) . The layer in which a neuron resides is closely matched with its birth in comparison 
to neurons in other layers(19) . For instance, the oldest neurons can be found in the 
deepest cortical layer whereas youngest neurons exist in the outermost layer(20, 21) . 
One can confirm the layer fate of a specified neuron by examining the expression of 
genes in that layer specific region(22) .  
 
 
During brain development, 
manner, i.e. adjacent neurons in one region maintain their neighbor
when they extend axons into another region
neurogenesis is allocated
ligands. These are expressed in
labels for the refinement of this neural map 
Ephrin signaling 
largest known family of receptor protein
cell-cell interaction with their cognate ephrin ligand
required for multiple aspects of
of axon guidance by forward signaling or promotion of angiogenesis for the distribution 
of the blood supply(14, 27)
two main classes based on sequence homology and structural composition
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many regions of the brain connect in a topographic 
-neighbor relationship 
 (23) . Responsibility during this stage of 
 to the Eph receptor tyrosine kinases and their
 gradients, and utilize signaling to serve as positioning 
(24, 25) . 
Erethropoeitin-producing hepatocellular (Eph) receptors are the 
-tyrosine kinases (RTKs) and function via direct 
(26) . Eph/ephrin signaling is 
 central nervous system development including mediation 
 . The ephrins and their EphR receptors are categorized into 
FIGURE 1: Stages of Neurogenesis
The first stage of neurogenesis is the induction and 
patterning of a neurogenic regions and specification of 
cell fates. The second stage is the birth and migration of 
neuron and glial cells. This is followed by guidance of 
axonal growth conges to form syn
  
 cognate ephrin 
, EphA and 
 
aptic connections.  
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EphB. The ephrins are composed of GPI anchored ephrin-A ligands and single-pass 
transmembrane ephrin-B ligands (Figure 2).  
 
Ephrin-As have a high affinity for EphA receptors and ephrin-Bs typically bind 
EphB receptors, although some promiscuity does exist (Figure 3). For instance, evidence 
of cross reactivity has been published where ephrin-A5 binds to and activates the EphB2 
receptor(28) . Examples of signaling capabilities include ephrin-A signaling pathways 
that are responsible for integrin function and Ephrin-B/EphB interactions that create the 
cell-cell repulsion that allow for organization of hindbrain segments(29, 30) . Ephrin-B2 
is also responsible for axon retraction in retinal ganglion cells from distinct retinal 
regions(31) . Post-embryonically, ephrin signaling plays roles in synaptic plasticity, nerve 
regeneration, cancer progression, and pathological angiogenesis (32-35) .  
EphR signaling can repulse axons from inappropriate target fields (Figure 1). 
EphRs and ephrins can also engage in bi-directional signaling. Forward signaling occurs 
when the ephrin sends positive cues to the receptor-bearing cell, whereas reverse 
signaling occurs downstream in the ligand-bearing cell. Reverse signaling is still not 
completely understood but what has been determined is that once activated, can be 
FIGURE 2: Structure and 
sequence homology of the Eph 
receptor and ephrin families 
Structural elements include: Cys-
rich, a unique cysteine rich domain 
found in the Eph receptors; FNIII, 
fibronectin type III motif; TM, 
transmembrane domain; GPI, 
glycosyl phosphatidylinositol 
membrane anchor; Core, a conserved 
core sequence in the ligands 
containing four invariant cysteines. 
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responsible for the opposite reaction such as growth cone extension instead of the typical 
growth cone collapse(31, 36) .  
 
As mentioned previously, connectivity mapping during the development of the 
visual cortex also relies on signaling from ephrins (37) . Also, negative signaling cues 
provided by EphrinA2 can regulate proliferation in addition to controlling the 
approximate number of neural cells in the progressing brain(38) . Finally, ephrin 
signaling is implicated in controlling growth cones and cortical column formation(39, 40) 
. In summary, the organization of the nervous system during early development relies 
heavily on signaling from EphRs and ephrins, playing critical roles in proper cortical 
development, axon guidance, apoptosis, and cell polarity(41-44) .  
Apoptosis in Early Neurogenesis 
During mammalian development, the elimination of cells by programmed cell 
death (PCD) is a necessary event that allows multicellular organisms to regulate cell 
numbers to remove cells that are functionally redundant(45) . Apoptosis can also 
eradicate cells that are potentially detrimental to the organism(45) . In addition to 
FIGURE 3: Binding interactions between ephrins and 
their receptors 
Dual colored indicates cross reactivity with the opposing 
classes. For example, ligand ephrin-A5 primarily interacts 
with the EphA family of receptors (yellow), although it more 
weakly interacts with the EphB family of receptors (purple). 
EphA10 specific binding partner has yet to be determined(35).  
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providing positive or negative directional cues for axon outgrowth, ephrin signaling is 
also required in apoptotic pathways to regulate brain size. Typically, programmed cell 
death (PCD) or apoptosis is required during normal mammalian development as a 
pruning mechanism to remove unnecessary structures, for example by removing skin 
between fingers and toes for segmented digits(46) .  
Ephrin signaling is essential to balance the size of the neural progenitor cell 
population in early neurogenesis. Furthermore, over-activation of EphA signaling in vivo 
increases the rate of apoptotic death(47, 48) . The mechanism for which apoptosis is 
initiated by ephrins is not fully understood although one recent study indicated that 
EphA7 was physically associated Caspase-8 to induce apoptosis(49) . Furthermore, 
EphA7 is co-localized with tumor necrosis factor receptor 1 (TNFR1) on the cell surface, 
a well-known player in the extrinsic apoptosis pathway (49). This interaction is lost once 
TNFR1 undergoes endocytosis, which confirms that apoptosis is initiated once EphrinA5 
binds to EphA7 and activates the death receptor TNFR1 by physical association(50) . 
Additional results from an in vivo study have shown that together, ephrinA5 and EphA7 
may function to balance cortical apoptosis to control overall neuronal mass(43) . This 
article demonstrated that over-expression of ephrinA5, driven from the EphA7 promoter, 
can lead to increased apoptosis. In addition, ephrinA5/A2 double mutant mice can display 
a reduction in apoptosis during neural patterning(43) .  
Based these in vivo results, we set out to explore whether EphA signaling has a 
role in neuroblast apoptosis during in vitro differentiation. The hypothesis is that (1) Eph 
receptor and ephrin expression is conserved in vitro during the stem cell-to-forebrain 
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differentiation and (2) EphR/ephrin signaling is functioning to balance apoptosis during 
neural development.  
In this study an in vitro system utilizing a stem cell-to-forebrain model with two 
different stem cell lines, Sox1-GFP and Oct4-GFP, was used to monitor the stem cell-to-
neuron transition while characterizing changes in apoptosis levels. Through the use of 
ezRNAi transfections, knockdown of EphA3, EphA4, and EphA7 receptor gene 
expression was monitored to evaluate which Eph receptor was contributing to the 
apoptotic effect individually. Findings from this project are the first in vitro assay 
allowing for visualization of how exactly EphA7 is participating in cortical maturation 
through apoptotic mechanisms. 
 
 
 
 
  
 
CHAPTER 
Stem Cell Culture and Maintenance
The following mouse embryonic stem cell lines (
the duration of these thesis studies;
cell types have been derived from the E14Tg2A cell line. 
propagated as feeder-free cultures on 
Glasgow modified Eagles medium
Glutamine, 1X non-essential amino acids
Penicillin/Streptomycin, and 10% 
factor was added to 50mL aliquots of filtered media prior to usage. 
seeded at 5x10
5
 cells in T
counted; media was replaced with fresh media on non
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2. MATERIALS AND METHODS 
 
 
mESCs) were used throughout 
 Oct4-GFP(51)  and Sox1-GFP(9)  (Figure 4
Both 
0.1% gelatin-coated plastic in 
 supplemented with 1mM Sodium Pyruvate
, 0.05mM Beta-mercaptoethanol, 1X 
fetal bovine serum. 2U/uL of leukocyte inhibitory 
5ml cultures were 
-12.5 flasks. These cultures were split every two days and 
-split days.  
 
Figure 4
expression in 
undifferentiated vs. 
differentiated cells
Oct4
row) are fluorescent and 
become non
upon differentiation.  
Cells are shown prior to 
differentiation. Sox1
cells (bottom row) are 
non
cells but express GFP 
during neural 
differentiation. Shown are 
Day 8 neuroblasts.
). These 
cell types were 
sterile-filtered 
, 2mM L-
 
: GFP 
 
-GFP stem cells (top 
-fluorescent 
-GFP 
-fluorescent as stem 
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Neural Differentiation 
Neuronal differentiation was carried out essentially as previously described (9)  
but with additional full volume media changes as necessary to remove cellular debris and 
dead cells. Differentiation was initiated at day 0 by plating stem cells on 0.1% gelatin-
coated plastic surfaces at low density in N2B27 media. Seeding densities were as follows; 
1.9x10
4
 cells per well of a 24-well plate or 2.1x10
5
 cells per 6cm plate. After 5 days post-
differentiation, the cells were re-plated onto poly-ornithine and laminin-coated surfaces 
and seeded as follows; 3.8x10
4
 cells per well of a 24-well plate or 4.2x10
5
 cells per 6cm 
plate.  
Alternative Media and Differentiation Supplements  
 An alternative to the Invitrogen supplied supplement is GEM 21 supplied by 
Gemini Biosciences. Neuroplex, which is compatible with the GEM 21 supplements, may 
be used in lieu of Neurobasal.  
Polymerase Chain Reaction (PCR) 
Forward and reverse primers for each fragment of the EphA receptors were 
designed by Bryan Lynn and ordered through Life Technologies (Appendix A). 
Polymerase chain reaction (PCR) was used to amplify 500-700bp fragments of each 
EphA receptor (EphA3, EphA4, or EphA7) that had been previously cloned into the 
pCR8/GW/TOPO plasmid by Cory Donelson (Figure 8). Second round PCR was used to 
extend a T7 promoter region onto the EphA receptor sequences for adequate 
transcription.  The same was followed for attaching the T7 promoter region on the GFP 
cDNA sequence. The 2X primer mix contained Taq, dNTPs, and PCR buffer. Aliquots of 
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products (2uL each) were analyzed via 2% agarose gel in TAE buffer stained with 
Ethidium Bromide.  
Table 1: PCR Reaction Mix and Thermocycler Programming 
PCR Reaction Amount 
 
Temp Time 
DI H2O 9.5 uL 1) 94
O
C 2 min 
2X PCR Mix 12.5 uL 2) 94
O
C 20 sec 
F. Primer (10uM) 1.0 uL 3) 50
O
C 30 sec 
R. Primer (10uM) 1.0 uL 4) 72
O
C 45 sec 
PCR Template 1.0 uL 5) Go to #2 35 times 
Total Mix 25.0 uL 6) 72
O
C 5 min 
 
RNA Transcription 
 In vitro RNA Transcription was carried out using the Ambion MEGA Script Kit 
supplied by Life Technologies using the protocol and incubation temperatures outlined 
below. Aliquots of products (1uL each) were analyzed via 2% agarose gel. The gel was 
prepared with DEPC treated TAE buffer and Ethidium Bromide. Gel running conditions 
were at 100 Volts in a DNase/RNase free environment (gel tank and running buffer).   
Table 2: RNA Transcription Reaction Mix and Thermocycler Programing 
Reaction Amount 
 
Temp Time 
DI H2O 6.0 uL 1) 37
O
C 4 hours 
NTPs 8.0 uL 2) 90
O
C 3 min 
10X Reaction Buffer 2.0 uL 
3) -0.1
O
C 
4) 70
O
C 
3 min 
3 min 
PCR Product DNA 2.0 uL 
5) -0.1
O
C 
6) 50
O
C 
3 min 
3 min 
T7 Enzyme 2.0 uL 7) -0.1
O
C 3 min 
Total Mix 20.0 uL 8) 25
O
C 3 min 
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Generation of siRNAs by RNase III Digest  
The double stranded ribonucleic acid (dsRNA) products were digested with 
RNase III (New England BioLabs Inc.) to yield 20-23 base pair fragments of dsRNA or 
small interfering RNA (siRNA) according to the protocol outlined below(52) . 
Table 3: RNase Digestion with NEB Shortcut RNase III 
Reaction Amount 
 
Temp Time 
DEPC H2O 65.0 uL 1) 37
O
C 30 min 
dsRNA (20ug) 5.0 uL 2) 0
O
C Place on Ice 
10X NEB Buffer 2.0 uL 3) Add 10uL EDTA Immediately 
10X MnCl2 2.0 uL 4) Purify Immediately 
NEB Shortcut RNase III 2.0 uL 
 Total Mix 100.0 uL 
 
siRNA Purification 
Fragmented siRNA was purified using RNA purification columns for small range 
RNA (Zymo Research). The procedure was performed as per the manufacture’s protocol.  
Transfections 
For EphA receptor knockdown, purified siRNAs were transfected into cells using 
Lipofectamine 3000 (Life Technologies), 24 hours prior to analysis. Cells in culture were 
allowed to adhere on the gelatin coated surfaces for 24 hours prior to transfection.  Cells 
in suspension were transfected directly into OPTIMEM and analyzed 24 hours later. 
pCAGGS-mCherry plasmid (kind gift of Bin Chen) was used as a co-transfection control 
to detect successful transfection of our RNAi constructs.  
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Table 4: Transfection with mCherry and siRNA Products 
Reagent Stock Concentration Final Concentration/Well 
Sham Transfected Lipo 3000 2.0uL 
GFP siRNA 265ng/uL 125ng, 250ng, or 500ng 
mCherry Plasmid (Prep 1) 
mCherry Plasmid (Prep 2) 
678ng/uL 
179ng/uL 250ng, 500ng, or 1ug 
EphA3 siRNA 365ng/uL 250ng or 500ng 
EphA4 siRNA 119ng/uL 250ng or 500ng 
EphA7 siRNA 566ng/uL 250ng or 500ng 
Total Volume Transfected  100uL/well 
 
Bioinformatics Assessment of Potential Cross-Binding 
Basic Local Alignment Search Tool (BLAST) searches of the GFP siRNA 
products were analyzed for cross binding to mCherry (Appendix B)(53) .  
Analysis of apoptosis by Annexin V binding and Flow Cytometry 
Apoptosis was characterized at various timepoints ranging from Day 1 to Day 10 
post-differentiation on the SH800 Sony Cell Sorter. Cells were lifted with Trypsin/EDTA 
and neutralized with 10% BSA/90% PBS. Cells were spun down and resuspended in 1X 
Binding Buffer (0.1M HEPES pH 7.4, 1.4M NaCl, and 25mM CaCl2 in 1X PBS). 5uL of 
Cy5-labeled Annexin-V (BD Biosciences) was added to 100uL of resuspended cells for 
15 minutes prior to adding 400uL of 1X Binding Buffer and analyzing by FACS. 
Annexin-V binds directly to phosphotidylserine, and can be used to indicate cells 
undergoing apoptosis versus necrotic cells. 25uL of a 5x 4',6-diamidino-2-phenylindole 
(DAPI) stain (1000X stock), used as a live/dead marker, was added to 100uL of 
resuspended cells and allowed to sit for 1 minute prior to analysis. Sox1-GFP and Oct4-
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GFP stem cells were used as our differentiation trackers to identify the percentage of 
neuroblast cells in the population. Color compensation to remove spectral overlap 
between mCherry and Annexin was carried using Sony SH800 software by analyzing 
single color controls.  
Confocal Microscopy 
Cell morphology was analyzed at various time points ranging from Day 0 to Day 
10 post-differentiation on a Zeiss LSM 700 confocal microscope. Post-transfection media 
was removed and cells were rinsed with PBS. 200uL of 1X Binding Buffer (0.1M 
HEPES pH 7.4, 1.4M NaCl, and 25mM CaCl2 in 1X PBS) was added to each well. 10uL 
of Cy5-labeled Annexin-V (BD Biosciences) was added to 200uL of rinsed cells for 14 
minutes prior to adding 50uL of 10X DAPI for an additional 1min. Solution was removed 
and cells were rinsed with PBS. 200uL of 1X binding buffer was added to each well then 
clusters of neuroblast were imaged. Oct4-GFP stem cells were used as our positive 
control.  GFP was targeted for knockdown with GFP siRNA at concentrations of 125ng, 
250ng, and 500ng per well. The corresponding % GFP expression was quantified by 
image analysis.  
  
 
Ephrin and EphR Expression During in vitro Neurogenesis
To answer the first question of whether or not 
is conserved in vitro during the stem cell
RTKs and their cognate ephrin
for EphAs and ephrin-As 
differentiations, we can confirm that EphR and ephrin transcript levels seen 
broadly mirror previously published
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CHAPTER 3. RESULTS 
 
 
Eph receptor and ephrin expression 
-to-forebrain differentiation; expression
-A ligands were examined. Quantification of mRNA levels 
was performed (Figure 5). Using our stem cell
 in vivo results (9) . 
 
FIGURE 5: Quantification of RT
EphA and ephrinA  
(A) mRNA expression levels for EphA receptors. (
mRNA levels of ephrin type A ligand expression.
are plotted relative to beta-actin mRNA and is 
representative of three independent differentiation 
experiments. (Clay Hembree and Martin Hudson 
unpublished observations) 
 of EphA 
-to-neural 
in vitro 
 
-PCR profiles of 
B) 
 Data 
 
At day 0, EphA2 is highly expressed and drops to almost zero at day 5 and returns to 
midlevel from day 8 to day 12. EphA4 expression is maintained throughout neural 
differentiation. EphA7 expression is negligible at day 
day 5 and steadily declines in expression throughout day 12 post
expression is first seen around day 8 and 
be observed at day 5 post
levels seen in vitro correspond closely
development sequentially through time
Oct4 is often used as a universal marker for stem cell fate and 
loss of Oct4 at day 5 post differen
day 5 post-differentiation, the majority of the cell population has lost stem ce
transformed into the desired neuronal fate
the pro-neural transcription factor Sox1
marker but it also required in maintaining the cell’s neural progenitor
decrease around day 5, after which
FIGURE 6: Quantitation of RT-PCR profiles of s
(A) mRNA expression level of Oct4 showing a loss of 
Sox2 (stem cell marker). Data are plotted relative to beta
(Clay Hembree and Martin Hudson unpublished observations)
15
0, elevates to its 
-differentiation. EphA3 
continues to day 12. EphrinA5 expression can 
-differentiation and lingers until day 12. Overall, the expression
 to expression profiles observed 
(11) .  
our 
tiation (Figure 6A). This data has also indicated that at 
, as demonstrated by high-level expression of 
 (Figure 6B). Sox2 can serve as a stem cell 
 state. We observe 
 it maintains levels throughout the time points tested.
tem cell and pro-neural markers  
expression at day 5. (B) mRNA levels of Sox1 (pro
-actin mRNA and is representative of three independent differentiations. 
 
highest peak at 
 
during forebrain 
data has shown 
ll state and 
a 
  
 
-neural marker) and 
 
The Sox1 pro-neural marker
differentiation, from day 5 onwards.
expression of Sox1 agrees with other publications 
We used antibodies to demonstrate that 
magnitude at the surface of 
fashion towards the central most portion of the ne
which is a signature for neuroblast identity, and EphA7 are co
good indication that EphA7 is expressed in developing neuroblasts
see EphA7 expression in 
playing during in vitro differentiation. 
 
 
Figure 7: Distinct region of EphA expression in neural tissue
(A) Neural masses at differentiation day 12. The arrow indicates a EphA7 positive region located at the periphery. (B) 
EphA7 expression at the cross-section between point’s 
Hudson unpublished observations)  
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 was expressed at constant levels throughout neural 
 The loss of Oct4 by day 5 and the increase in 
(9, 54) .  
EphA7 expression is detected in highest 
in vitro-generated neural masses and decreasing in a gradient 
ural mass (Figure 7).   
-localized
(55)
this cell type, we do not know what role Eph/ephrin signaling is 
 
 
 
  
m-n and p-q as noted on Figure 6A. (Clay Hembree and Martin 
Because Nestin, 
, this provides a 
 .  Although we 
 
 
Synthesis and Purification of
Because the role of
understood, we used a knockdown system involving 
Genetic mutations in the live mouse model are considered to be the gold standard for 
examining gene function in vivo.  However, the average time to generate a mouse 
knockout takes about 18 mont
university laboratories. Here, we implement an in vitro model, which uses siRNA to 
transiently knock down gene function allowing for a rapid, reliable, and cost
method that can be implement
gene silencing is a powerful genetic manipulation tool
works by eliciting destruction of targeted mRNA stands by binding to the com
sequence promoting rapid destructio
overlapping, EphA receptor fragments. In addition, GFP siRNAs were generated for use 
in assay validation and controls.
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 EphA Receptor siRNA  
 Eph/ephrin signaling during in vitro differentiation
siRNA to expose the role of EphA7. 
hs, is quite costly and completely unfeasible in smaller 
ed in essentially any laboratory. Transfecting siRNAs for 
(56) . The mechanism of siRNA 
n(52) . siRNAs were generated from cloned, non
 
 
FIGURE 8: Plasmid for cloning EphA receptors 
 is not well 
-effective 
plementary 
-
 
 
Polymerase chain reaction (PCR) 
of each EphA receptor (EphA3, EphA4, or EphA7)
8). This PCR step also allowed us to add a T7 RNA polymerase recognition site onto 
both ends of each fragment. 
Ethidium Bromide (Figure 9). Each cloned DNA fragment was a single ba
indicates purity of each amplicon
EphA4 is 567 base pairs, EphA7 is 639 base pairs, and the GFP fragment is 
pairs in length.  
The DNA fragments were then used as templates for 
reactions to generate dsRNA 
III, yielding 20-23 base pair fragments of dsRNA. These were purified
purification columns. RNaseIII digestion was confirmed by agarose gel electrop
RNase/DNase free environment (Figure 11). siRNA products were quantified via 
Nanodrop (Table 5). Due to the low yield of GFP siRNA, the dsRNA 
re-purified. It was concluded that preparation error had occurred because preparati
had adequate amounts of siRNA post
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was used to amplify the specified
, and a GFP cDNA sequence (Figure 
Each DNA product was analyzed by agarose gel stained with 
. The sizes were appropriate; EphA3 is 527 base pairs, 
in vitro
(Figure 10), which was subsequently digest
was
-purification.  
 
FIGURE 9: DNA Templates 
Aliquots of products (2uL each) containing 
the T7 promoter site were analyzed via 2% 
agarose gel in TAE buffer stained with 
Ethidium Bromide. 
 region portion 
nd that 
750 base 
 transcription 
ed with RNase 
 using RNA 
horesis in 
 re-digested and 
on 2 
 
 
 
Table 5: Nanodrop quantification 
siRNA 
EphA3 
EphA4 
EphA7 
GFP (Prep 1) 
GFP (Prep 2) 
 
Implementation of a Positive Control
To validate the siRNA delivery system, a GFP knockdown positive control was 
implemented. Initially a low dose (50ng) of GFP siRNA was transfected 
stem cells and a time-course was applied to test the limits of the knockdown effect 
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of siRNA Products 
Concentration  
375ng/uL 
119ng/uL 
566ng/uL 
5ng/uL 
265ng/uL 
 
FIGURE 11: siRNA Products 
 Aliquots of purified siRNA (2uL each) analyzed by 3% agarose gel in 
stained with Ethidium Bromide. (Frank Tulenko and Marcus Davis 
unpublished observations) 
 
FIGURE 10: RNA Transcripts 
 Aliquots of dsRNA (2uL each) analyzed by 2% agarose gel in 
stained with Ethidium Bromide run in a DNase/RNase free 
environment. (Frank Tulenko and Marcus Davis unpublished 
observations) 
 
 
into Oct4-GFP 
 
(Figure 12). The 50ng concentration was selected 
data(57) .  
We observed a modest decrease in GFP expression after 96 hours post
transfection. However, because 
siRNA was increased to concentra
Phenotypic GFP expression was recorded through confocal microscopy to show the 
decrease in GFP fluorescing cells (Figure 
total GFP fluorescence to total transmission data. From the results it is easy to conclude 
that a range of 125ng-500ng is sufficient to 
GFP fluorescence, so it was decide
EphA knockdown. At 500ng GFP siRNA threshold levels exceed the amount of 
lipofectamine and less siRNA is transfected, increase in GFP expression is observed.
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based upon previously published 
 
a dramatic knockdown effect was desired, the GFP 
tions of 125ng, 250ng and 500ng of siRNA
13). This data was quantified by comparing 
detect a concentration-dependent 
d that 250ng of siRNA would be adequate to target 
77.3
71.1
63.5 66.3
50ng GFP 50ng GFP 50ng GFP
48hrs 72hrs 96hrs 120hrs
FIGURE 12: GFP Knockdown Time
Concentrations of 50ng of purified GFP siRNA 
were transfected into cells seeded at 19,000 
cells/well and were allowed to incubate for 24 
hours in OPTIMEM before returning to stem 
cell media.  Populations of cell were counted 
on the BD Accuri and were gated
appropriately. (Top) Flow cytometry data. X
axis measuring GFP fluorescence. Y
measuring forward scattering. Cells gated as 
positive for GFP fluorescence are gated within 
the dotted lines. (Left) Quantification of flow 
cytometry data, GFP-positive ce
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250ng 
siRNA
500ng 
siRNA
FIGURE 13: Confocal analysis of 
GFP knockdown  
Concentrations of 125ng, 250ng, and 
500ng of GFP siRNA were transfected 
into cells 24 hours prior to analysis. 
The Sham transfection was 
lipofectamine 3000 alone. Cell clusters 
for each condition were randomly 
selected for analysis. Measurements 
were calculated by dividing thresholded 
GFP fluorescence pixels by the total 
pixels in the cluster (measured from the 
transmitted light channel).  
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Co-Transfection Optimization 
An mCherry co-transfection plasmid was used to detect successful transfection of 
the siRNA products. This will allow for selective gating to exclude untransfected cells 
from the population in evaluation. mCherry transfections were optimized in mESC media 
and OPTIMEM for stem cells and N2B27 and OPTIMEM for neurons (Figure 14). 750ng 
of plasmid was selected as a target range based upon recommendation by the 
Lipofectamine 3000 protocol. Throughout the transfection experiments, all of the cells 
were able to maintain resonable levels of viablity based on the percentage of live cells 
reported.  
Stem cells were transfected with mCherry in both mESC media and OPTIMEM 
with about 30% transfection efficiency (Figure 14A). Therefore it can be concluded that 
stem cells posses the ability to be transfected in both stem cell media and OPTIMEM. 
Neurons were transfected with less efficiency in the OPTIMEM (13%) than the N2B27 
media (24%). Based on the live cell population reported, the neuroblasts did not suffer 
from the OPTIMEM media, although rather less mCherry was taken up by the 
neuroblasts (Figure 14B).  
Upon the deduction that stem cells are more easily transfected than neuroblasts 
(Figure 14C), it was recommended to use GFP siRNA knockdown on day 3 neuroblasts 
to test their ability to uptake GFP siRNA and to yield an observable reduction in GFP 
fluorescence (Figure 15). Cells were assessed 24, 48, and 72 hours after transfection. The 
experiment was set up in parallel with Day 0 stem cells for comparison purposes.  
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FIGURE 14: mCherry transfection optimization
(A) Sox1-GFP undifferentiated stem cells were 
transfected with Lipofectamine 3000 alone and 750ng 
of mCherry plasmid. (B) Sox1-GFP differentiated 
Day 1 neuroblasts were transfected with 
Lipofectamine 3000 alone and 750ng of mCherry 
plasmid. 24 hours post-transfection, the cells were 
moved back to regular media and analyzed 48 hours 
post-transfection.  (C). mCherry expressing cells were 
quantified by the Sony SH800.  
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FIGURE 15: Comparison of GFP knockdown in Day 0 and Day 3 Oct4
Cells were lifted and plated on gelatin
Concentrations of 250ng of GFP siRNA along with 1ug mCher
3 neuroblast 24 hours prior to analysis. At 24 hours the OPTIMEM was removed and replaced with (A) stem cell or (B) N2B27 
media respectively. (C) Quantified population of GFP positive stem c
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-coated surfaces at 19,000 cells/well and allowed to settle for 24 hours prior to transfecting. 
ry were transfected into Oct4-GFP (A) day 0 stem cells or (B) day 
ells and (D) population of GFP positive neuroblasts. 
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It was established
neuroblasts and has a lasting knockdown effect out until 72 hours post
These finding suggest that mCherry can be considered a practi
and that both stem cells and neuroblast
Apoptosis Method Validation
Flow cytometry was used to characterize apoptosis throughout the duration of this 
thesis. Apoptosis was assayed a
differentiation, using both the BD Accuri 
Sorter. The Accuri automatically establishes laser and filter setting
requires some manual integration parameters to ensure optimal data collection. 
The first step when working with the Sony is to calibrate 
control. Sox1-GFP day 0 stem cells were used as the negative control in these 
experiments because they contain no flu
resuspended in 1X Binding Buffer and the
population in the center of the viewing window (Figure 16
recorded to establish limits of detection
 
FIGURE 16: Gating for a negative control 
Sox1-GFP stem cells were used to set up each laser setting. Brilliant Violet = DAPI (405nm), FITC = GFP (488nm), 
PE = mCherry (561nm), and APC = Cy5
25
 that GFP knockdown was observed in both stem cells and 
cal co-transfection control 
s are susceptible to gene silencing via siRNA. 
 
t various timepoints ranging from Day 1 to Day 10 post
flow cytometer and the Sony 
s whereas the Sony 
with
orophores. The cells were spun down and 
n each laser was set up to target the cell 
). Single color controls can be 
 for each fluorophore (Figure 17). 
 
 
-Annexin (638nm).   
-transfection. 
 
-
SH800 Cell 
 
 the negative 
 
  
 
 
 
Automatic compensation can then be calculated using the gating from the 
negative control and single color controls. 
can be applied to any subsequent data set (Figure 18
is required to fine-tune the removal of spectral overlap. In 
mCherry co-transfection plasmid to detect successful transfection of our RNAi 
constructs, thought to be a
the use of both mCherry and Annexin on the FACS 
major spectral overlap. Because of this,
experiments.  
FIGURE 17: Gating for single color controls
(A) Brilliant Violet = DAPI (405nm) Sox1
Stem Cells. (C) PE = mCherry (561nm) Sox1
(638nm) Sox1-GFP Stem Cells incubated with 1X Cy5
and can be used to indicate cells undergoing apoptosis versus necrotic ce
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The resulting calculations are generated and 
). Occasionally manual compensation 
our case, incorporation of 
 useful efficiency control, led to complications
required manual compensation due to 
 mCherry was not used in subsequent
 
-GFP cells incubated with 1X DAPI for 1min. (B) FITC = GFP (488nm) Oct4
-GFP stem cells transfected with mCherry Plasmid. (D) APC = Cy5
-Annexin for 15 minutes. Annexin-V binds directly to phosphotidylserine, 
lls. 
 
the 
. Unfortunately, 
 
-GFP 
-Annexin 
 
mCherry expression
very strong promoter, which 
signal to overpower that of the weaker Cy5 fluorophore.
between mCherry and Annexin (Figure 19
compensation (Figure 19B
quadrant adjusted the color compensation matrix
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 is driven by the pCAGGS chicken actin promoter
leads to very high expression levels of mCherry causing the 
 The major spectral overlap 
A) was accommodated via manual 
). Dragging the mCherry population back to its respective 
 (Figure 19C).  
FIGURE 18: Automatic color compensation 
The automatic color compensation matrix was 
calculated using single color controls. 
 
. This is a 
 
 
 
 
 
In order to only account for live cells during the apoptosis assay, all dead cells 
need to be removed from the whole cell population in each i
performed by incubating cells with 1X 
minute prior to analysis. D
DAPI, which binds with high affinity to DNA whereas live cells exclude this dye. 
viewed on a flow cytometry plot, the DAPI
the operator to adjust the 
The presentation of phosphatidylserine to the outer leaflet of the cell membrane is 
a characteristic hallmark of apoptosis. 
undergoing apoptosis during the assay, cells were incubated with Cy5 
which has a high binding affinity for phosphotidylserine. To 
28
ndividual sample. This was 
DAPI (4',6-diamidino-2-phenylindole
ead cells have ruptured membranes and are permeable to 
-stained population is clearly visible, allowing 
live/dead gate appropriately (Figure 20).  
To determine the approximate number of cells 
labeled 
validate our assay and 
FIGURE 20: Live/Dead gating using DAPI 
FSA = Forward scattering which measures the size of each 
individual cell as an event. BSC = Back scattering which 
measure cell complexity. (Left) Fragmented cells and 
cellular debris is found during events measuring less than 
238 on the FSC horizontal axis.  (Right) Cells staining 
positively for DAPI are gated appropriately and not 
factored into the live cell population.  
FIGURE 21: Applying Manual 
Color Compensation Calculation 
Matrix  
(A) Spectral Overlap 
mCherry and Cy5-Annexin 
emission spectra above, there is 
heavy spillover from mCherry 
channel into the Cy5
emission region. (B) Sample = 
Neuroblast mCherry Transfected 
Cells. (Left) No compensation 
applied. (Center) Results from 
Automatic compensation from single 
color control matrix. (Right) (C) 
Manual Compensation applied by 
dragging mCherry population back to 
the upper right quadrant where 
mCherry is gated appropriately. 
 
FIGURE 21: Cy5-Annexin Shift  
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induce a major shift in the
(H2O2) was used to increase cellular stress 
EphA Receptor Knockdown
Investigation of the role of EphA receptors in stem cell maintenance was 
prompted by our observation that
differentiation (Figure 2). 
role in maintaining cells in the stem state. To address this, 
siRNAs were transfected into 
analysis (Figure 22).  
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 Cy5-Annexin V positive cell population, hydrogen peroxide 
and trigger apoptosis (Figure 21
  
 in Stem Cells  
 EphA4 is expressed in mESCs and throughout 
This lead us to ask whether EphA3, EphA4 or EphA7 had any 
EphA3, EphA4, and EphA7 
undifferentiated Oct4-GFP stem cells 24 hours
Sample % Difference
Sham 
GFP 
EphA3 
EphA4 
EphA7 
).  
 prior to 
 
 
0 
16.9 
1.5 
3.1 
0.8 
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The percent difference between the sham and the GFP siRNA transfected sample 
is about 17% thus confirming that the transfections had occurred. There is not a 
significant difference between the EphA siRNA transfected samples and the sham 
transfected. To increase the probability of observing a shift in GFP expression, mCherry 
was added to gate specifically for the siRNA transfected samples (Figure 23). 
 
Oct4-GFP expression was maintained at about 80% throughout, irrespective of 
which EphA was knocked down (Figure 22) and even with transfection gate provided by 
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FIGURE 23: mCherry co-transfection with EphA 
siRNA in Oct4-GFP stem cells  
Undifferentiated mouse embryonic stem cells were lifted 
and transfected in suspension with 250ng of EphA 
siRNA and 500ng of mCherry. Then plated onto gelatin-
coated wells of a 24-well plate. Cells were analyzed by 
FACS using DAPI staining for live/dead gating.  Error 
bars are representative of experiment performed in 
triplicate.  
FIGURE 22: GFP knockdown on day 0 stem cells  
Undifferentiated mouse embryonic stem cells were lifted 
and transfected in suspension with 500ng of siRNA and 
plated onto gelatin-coated wells of a 24-well plate. Cells 
were analyzed by FACS using DAPI staining for 
live/dead gating.  Error bars are representative of 
experiment performed in triplicate.  
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the mCherry co-transfection plasmid (Figure 23) there is not a dramatic difference 
between EphA KD GFP expressions. It can be concluded that EphA signaling has no 
obvious role in maintaining stem cell state.  
Bioinformatics Assessment of Potential Cross-Binding 
To ensure that transfected GFP siRNA was not knocking down our mCherry co-
transfection control, we performed BLAST searches of the GFP siRNA products to 
analyze for possible cross binding to mCherry (See Appendix B)(53) . In order to achieve 
degradation of mRNA, 100% homology matching of 23 base pairs must be accomplished. 
Less than 100% may possibly provide disruption in translation but not necessarily 
targeted degradation. Cherry and GFP react at 100% with 23 base pairs and 100% with 
18 base pairs. Keeping in mind that at 100% homology match for a 23 base pair fragment 
out of a possible 750 base pair length GFP fragment is about a 3% chance of providing a 
gene silencing effect. However, we may still observe an off-target effect from GFP to 
mCherry. 
Alternative Media and Differentiation Supplements 
A cost effective option to the Invitrogen supplied supplement is GEM 21 supplied 
by Gemini Biosciences. Differentiation was initiated at day 0 by plating cultured stem 
cells on 0.1% gelatin-coated plastic surfaces at low density in N2B27 media. An initial 
seeding density of 2.1x10
5
 cells per plate was initiated on a total of 6x6cm plates.  
However, we could not generate any viable neurons using this tissue culture 
supplement.  The neurons when resuspended in GEM 21 N2B27 will adhere to gelatin-
coated surfaces as normal but upon day 2 post-differentiation, they are struggling to 
 
survive.  In lieu of Neurobasal, Neuroplex, which is compatible with the GEM 21 
supplements, was proven equivalent to the Neurobasal media during stem cell 
differentiations (data not shown). 
EphA Receptor Knockdown
To test whether siRNA knockdown
EphA4, and EphA7 siRNA 
and analyzed by flow cytometry 24 
Accuri (data not shown) 
results. We find that 72 hours post
entire cell population, 
transfected sample, which 
knockdown resulted in a decrease of apoptotic cells in the sample population concluding 
that EphA7 plays a role in 
knockdown provided minimal changes in apoptosis levels indicating they play no roles in 
regulating cell progenitor pool size. 
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 in Neuroblasts  
s were effective in neuroblast
transfections were performed at Day 5 post
– 72 hours later. The samples were run on both the 
and the Sony (Figure 24); both instruments yielded comparable 
-transfection, apoptotic cells were around 8% 
and the only significant difference was the EphA7 siRNA 
was 5.8% Cy5 positive. This result gave us insight that
promoting apoptosis.  Furthermore, EphA3 and EphA4 
 
s, GFP, EphA3, 
-differentiation 
of the 
 EphA7 
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We wanted to determine what time point gave us the best observation of 
apoptosis.  To do this, we examined assayed for apoptosis at 24, 48, and 72 hours post-
transfection. In this time course a gradual reduction in GFP expression was observed, 
which is to be expected of Oct4-GFP cells leaving the stem state and entering pro-
neuronal fate (data not shown). The EphA7 siRNA transfected sample is a third less Cy5 
positive than the mCherry transfected sample at 24 hours (Figure 25). However, at 48 and 
72 hours post-transfection the EphA7 siRNA knockdown sample yields comparable 
levels of Cy5 positive cells when compared to the mCherry-transfected control. This 
suggests that 24 hours is optimal to view changes to apoptosis level due to EphA 
knockdown. At 48 and 72 hours post-knockdown, it is likely that the knockdown by 
siRNA is no longer effective (Figure 25). Whereas, at Day 5 EphA7 expression levels are 
maximal (Figure 2) and knockdown effects may take up to 72 hours to observe a shift in 
apoptotic activity (Figure 24).  
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FIGURE 24: EphA knockdown in neuroblast 
Sox1-GFP mouse embryonic stem cells were plated onto 
gelatin coated 6cm dishes at low density. At day 5 they 
were transfected in Optimem for 24 hours then the media 
replaced with N2B27 media. Cells were lifted and 
analyzed 72 hours post-differentiated.  
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 Following out extensive method development, we assayed a single time point in 
triplicate using sham vs. EphA7 siRNA transfected samples. These were run without the 
mCherry co-transfection plasmid to remove any subjectivity involved with manual 
compensation. We found a 60% decrease in Cy5-AnnexinV stained cells after 
transfection with EphA7 siRNA when compared to sham-transfected controls (Figure 
26). Student t-test of the two samples lead to a P value =0.0144. We conclude that 
apoptosis levels in EphA7 siRNA-treated cells are significantly different from sham 
controls. This data strongly suggest that EphA7 is playing a role in promoting apoptosis.  
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FIGURE 25: Day 3 neuroblasts knockdown 
time course  
Oct4-GFP mouse embryonic stem cells were 
plated onto gelatin-coated surfaces at low 
density in N2B27 differentiation media. At day 
3 they were transfected in optimem for 24 hours 
with EphA7 siRNA and a co-transfection 
control (mCherry). After 24 hours the cells were 
returned to N2B27 media. They were lifted and 
analyzed 24, 48, and 72 hours post-transfection. 
The samples were run on the SH800 and 
analyzed for apoptosis using Annexin-Cy5 
staining.  
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FIGURE 27: Apoptosis analysis on day 7 neuroblasts.  
Day 6 neuroblast were lifted off laminin-coated surfaces, 
transfected in OPTIMEM and returned to laminin
wells of a 24-well plate. 24 hours post siRNA transfection; 
the cells were stained with Cy5-AnnexinV and DAPI then 
analyzed on the SH800 in triplicate.  N = 3 experiments.  
Error bars are standard error of the mean. 
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CHAPTER 4. DISCUSSION 
 
This thesis aimed to investigate the role of EphA receptor signaling in apoptosis 
during in vitro neurogenesis. Our original hypothesis was that (1) Eph receptor and 
ephrin expression is conserved during in vitro stem cell-to-forebrain differentiation and 
(2) EphR/ephrin signaling was functioning to balance apoptosis during neural 
development. The hypothesis was tested directly by developing an in vitro system using a 
stem cell-to-forebrain model with two different stem cell lines, Sox1-GFP and Oct4-GFP, 
to monitor the stem cell-to-neuron transition while characterizing changes in apoptosis 
levels. The Sox1-GFP cell line is a knock-in reporter ES cell line in which there is a 
random insertion of a Sox1 promoter driving GFP expression. In the neuroectoderm of 
the mouse embryo, Sox1 is the earliest marker of neural development (58) . The Oct4 
gene was discovered as a primary maintenance gene to maintain stem cell pluripotency 
and gave rise to the Oct4-GFP mESC line in 2003 (59, 60) . Layer-specific cortical 
neurogenesis is conserved during embryonic stem cell to neuron differentiations(61) . 
Our qRT-PCR data support and extend these observations. In addition, we find that Eph 
and ephrin expression during in vitro differentiation broadly mirrors previously published 
in vivo data, further suggesting that we can recapitulate elements of cortical neurogenesis 
in vitro (11) . 
An additional goal was to investigate if EphA receptors had any role in 
maintaining stem cell pluripotency. Currently there is no literature surrounding the idea 
that Eph/ephrin signaling is involved in maintaining stem cell pluripotent state. We chose 
 37
to investigate this because preliminary data shows EphA4 expression in mESCs and 
throughout differentiation (Figure 2). We found that Oct4-GFP expression was 
maintained at about 80% throughout, irrespective of which EphA was knocked down, 
suggesting that EphA signaling has no obvious role in the maintenance of stem cell fate. 
The inkling that EphR/ephrin signaling may be functioning in vitro to balance apoptosis 
during neural development was prompted upon discovery of a recent publication that 
displays an obvious reduction in apoptosis due to loss of EphA7 by mutation in an in vivo 
study(55) . This work demonstrates the significance of region-specific apoptosis 
involving ephrin signaling (55) . Data revealed in this thesis provides substantiating 
evidence that EphA7 knockdown led to a reduction in apoptosis levels during in vitro 
neural differentiation, indicating that EphA7 promotes apoptosis during in vitro neural 
differentiation. This concurs with data from an in vivo study that implicate ephrinA5 and 
EphA7 in balancing cortical apoptosis to control overall neuronal mass (43) . Additional 
support demonstrates that over-expression of ephrinA5, driven from the EphA7 promoter, 
can lead to increased apoptosis (62) . 
We assayed apoptosis using flow cytometry. Cy5-labeled Annexin-V was used to 
quantify the cells undergoing apoptosis by binding to cell-surface phosphotidylserine. 
Also, DAPI staining was used to identify dead cells (which could potentially also display 
phosphatidyl serine on the cell surface) because it binds very quickly to dead cells’ DNA 
by penetrating the partially ruptured cell membranes. This proved to be useful for 
live/dead gating of cell populations. In addition, incorporation of the mCherry co-
transfection plasmid to detect successful transfection of our RNAi constructs was thought 
to be a useful efficiency control. Unfortunately, the use of both mCherry and Cy5-
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AnnexinV on the FACS required the use of manual compensation due to major spectral 
overlap, hence mCherry was removed from subsequent experiments. mCherry is driven 
by the pCAGGS promoter, which is a very strong promoter, this lead to very high 
expression levels of the mCherry plasmid causing the signal to overpower that of the 
weaker Cy5 fluorophore.  
Elaboration of a four-color fluorescent experiment enabled the ability to quantify 
cells in different stages of apoptosis and death in different cell populations. Transfecting 
siRNA for successful gene inhibition was proven as a practical method.  Findings from 
this project allowed for visualization of how exactly EphA7 is participating in cortical 
maturation through apoptotic mechanisms. 
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CHAPTER 5. CONCLUSIONS AND FUTURE WORK 
 
Conclusions 
Because ephrins play a role in neurogenesis and literature has shown that they can 
control brain size in vivo, our ability to recapitulate these results during an in vitro study 
has proven to be valuable discovery that can contribute to scientific advancement. The 
primary objective of this thesis was to use a stem cell model of neural differentiation to 
determine if EphA3, EphA4, or EphA7 had any role in apoptosis during in vitro 
differentiation.  
To investigate if EphA receptors had any role in maintaining stem cell 
pluripotency, EphA knockdown in Day 0 cells did not cause them to differentiate. The 
GFP expression in Oct4-GFP stem cells was maintained levels throughout the 
transfection with siRNA from EphA3, EphA4, and EphA7. This concluded that cells 
could still maintain their pluripotent state and resist differentiation during EphA receptor 
knockdown generating a negative result.  
Knocking down GFP expression in Oct4-GFP stem cells and Sox1-GFP 
neuroblasts validated the siRNA transfection assays. We then assayed apoptosis during in 
vitro neural development by using ezRNAi transfections to knockdown of EphA3, 
EphA4, and EphA7 receptor expression. The knockdown of EphA3 and EphA4 had little 
to no effect on the number of Cy5 positive cells indicating that they have no role in the 
regulation of apoptosis during neuroblast differentiation. Finally, EphA7 knockdown lead 
to a reduction in apoptosis at all stages of neural differentiation assayed (day 3 through 
day 8). This finding confirms our original hypothesis to be correct. 
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Demonstrating that EphA7 receptor signaling plays a role in neuroblast survival 
during in vitro differentiation is a significant and novel body of research. Future findings 
may prove to be useful in the discovery and outline of more connections in other 
developmental processes as well as providing potential molecular targets for therapeutic 
applications in oncology(63) . 
Future Work  
Aside from what has been delineated in the finding of this thesis, additional 
experiments are worth mentioning in this chapter. One additional objective is to 
determine the mechanism of apoptosis triggered by Eph/ephrin signaling in vitro. 
Whether it is cross talk via death receptors or direct interaction with one or more of the 
caspases is not known and would make for a compelling future project.  
Working with neural spheres in culture followed by Cryostat-sectioning and 
immunostaining for known apoptotic markers (e.g. cleaved caspase or TUNEL staining) 
could provide the opportunity to gain further insight into the role of apoptosis in neuronal 
precursor cells. This method allows for retention of neuronal morphology in relation to 
surrounding cells and may represent a closer in vitro approximation to in vivo neural 
development. For instance, by exploring neurospheres in culture we can examine the 
neuronal layering associated with in vivo cortical development.  
Alternatively, by plating cells onto cover slips, we can assay for apoptosis via 
immunohistochemistry. We also plan to stimulate apoptosis using antibody-clustered 
EphrinA5 and expect to see an increase in apoptosis. Lastly, continuing research includes 
studying additional receptors, additional ligands, and/or additional timepoints. 
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APPENDIX A 
 
mh844 Primer designs for ezRNAi  12.17.13 Products on intended target 
 
>NM_010140.3 Mus musculus Eph receptor A3 (Epha3), mRNA  
 product length = 527  
Forward primer  1  GAGCGGAGCATGGTAACTTCT  21  
Template        8  .....................  28   
Reverse primer  1    TCGTGAACTGATGCTCTCGG  20  
Template        534  ....................  515   
 
Products on intended target 
 
>NM_007936.3 Mus musculus Eph receptor A4 (Epha4), mRNA  
 product length = 567  
Forward primer  1     AGCAACTTGGTCTGCAAGGT  20  
Template        2323  ....................  2342   
Reverse primer  1     AACCACGGCTTCTAGTGTCG  20  
Template        2889  ....................  2870   
 
Products on intended target 
 
>NM_010141.3 Mus musculus Eph receptor A7 (Epha7), transcript variant 1, mRNA  
 product length = 639  
Forward primer  1     AGGCTCTTCGCTGCTGTTAG  20  
Template        1524  ....................  1543   
Reverse primer  1     TGCACCAATCACACGCTCAA  20  
Template        2162  ....................  2143   
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Primers (ordered 12.17.13) 
EphA3F1 GAGCGGAGCATGGTAACTTCT   
EphA3R1 TCGTGAACTGATGCTCTCGG   
EphA4F1 AGCAACTTGGTCTGCAAGGT   
EphA4R1 AACCACGGCTTCTAGTGTCG   
EphA7F1 AGGCTCTTCGCTGCTGTTAG   
EphA7R1 TGCACCAATCACACGCTCAA   
 
Forward primer- 5' -TCACTATAGGGAGAG- original forward primer- gene-3' 
Reverse primer-5' -TCACTATAGGGAGAC- original reverse primer-gene-3' 
 
Redesigned primer set: 
 
EphA3F1 TCACTATAGGGAGAGGAGCGGAGCATGGTAACTTCT   
EphA3R1 TCACTATAGGGAGACTCGTGAACTGATGCTCTCGG   
EphA4F1 TCACTATAGGGAGAGAGCAACTTGGTCTGCAAGGT   
EphA4R1 TCACTATAGGGAGACAACCACGGCTTCTAGTGTCG   
EphA7F1 TCACTATAGGGAGAGAGGCTCTTCGCTGCTGTTAG   
EphA7R1 TCACTATAGGGAGACTGCACCAATCACACGCTCAA 
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